Reports Q3 revenue $70.45M, consensus $44.87M. “We have continued the steady transformation of Novavax (NVAX) and are proud of our progress this quarter,” said John Jacobs, President and Chief Executive Officer, Novavax. “This year we have relaunched the Company with a focus on R&D and partnerships intended to position us well for long-term growth and profitability.”
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVAX: